Clinical Trials List
2023-11-01 - 2025-09-12
Phase I
Not yet recruiting2
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu 無
- 梁逸歆 無
- Jih-Hsiang Lee 無
- 徐偉勛 無
- Kun-Huei Yeh 無
- 陳國興 無
- Hsiang-Fong Kao 無
- 林昭文 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 劉奕廷 無
- Yan-Shen Shan 無
- 顏志傑 無
- Shang-Yin Wu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
146 participants
